{
    "type": "ETF",
    "ucits": true,
    "replication_method": "physical",
    "swaps": false,
    "derivatives": false,
    "leverage": false,
    "inverse": false,
    "complex_factors": [],
    "classification": "non-complex",
    "supporting_data": "The UBS (Lux) Fund Solutions - Solactive China Technology UCITS ETF is a UCITS-compliant ETF that tracks the Solactive China Technology Index using a representative sampling strategy with portfolio optimization. The fund primarily invests in equities of Chinese technology companies and uses physical replication as confirmed by the factsheet. While the KIID and PRIIPs KID mention that derivatives may be used occasionally for efficiency or where direct replication is impractical, these are not inherent to the investment strategy but rather for risk management or operational purposes, so derivatives are marked false. There is no mention of synthetic replication, swap agreements, or counterparty risk beyond standard collateral policies. The fund does not employ leverage, inverse or amplified exposure, nor does it invest in complex underlying assets such as contingent convertible bonds or structured products. The risk profile is high (category 5 in KIID, 6 in PRIIPs KID) due to equity exposure in emerging markets and associated volatility, but this does not imply complexity under MiFID II. Costs are straightforward with a TER around 0.47%-0.5%, no performance fees, and no complex fee structures. The PRIIPs KID explicitly states the product 'is not simple and may be difficult to understand' due to market volatility and emerging market risks, but this relates to risk rather than structural complexity. No capital protection or structured features are present. The factsheet confirms physical full replication and no use of swaps or synthetic structures. Therefore, the ETF is classified as non-complex under MiFID II criteria."
}